ATE408403T1 - Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon - Google Patents
Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davonInfo
- Publication number
- ATE408403T1 ATE408403T1 AT02745700T AT02745700T ATE408403T1 AT E408403 T1 ATE408403 T1 AT E408403T1 AT 02745700 T AT02745700 T AT 02745700T AT 02745700 T AT02745700 T AT 02745700T AT E408403 T1 ATE408403 T1 AT E408403T1
- Authority
- AT
- Austria
- Prior art keywords
- damage
- treatment
- deramciclan
- decrease
- pharmaceutical composition
- Prior art date
Links
- 230000003920 cognitive function Effects 0.000 title abstract 2
- 230000007423 decrease Effects 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000003340 mental effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0103017A HUP0103017A3 (en) | 2001-07-18 | 2001-07-18 | Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE408403T1 true ATE408403T1 (de) | 2008-10-15 |
Family
ID=90001562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02745700T ATE408403T1 (de) | 2001-07-18 | 2002-07-18 | Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20040171696A1 (de) |
| EP (1) | EP1408940B1 (de) |
| JP (1) | JP2004537548A (de) |
| KR (1) | KR20040017326A (de) |
| CN (1) | CN1545410A (de) |
| AT (1) | ATE408403T1 (de) |
| CA (1) | CA2453834A1 (de) |
| CZ (1) | CZ200460A3 (de) |
| DE (1) | DE60228968D1 (de) |
| EA (1) | EA006897B1 (de) |
| HU (1) | HUP0103017A3 (de) |
| IL (1) | IL159841A0 (de) |
| PL (1) | PL365258A1 (de) |
| RS (1) | RS4904A (de) |
| SK (1) | SK312004A3 (de) |
| UA (1) | UA78714C2 (de) |
| WO (1) | WO2003007926A2 (de) |
| ZA (1) | ZA200400481B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0301537A3 (en) * | 2003-06-03 | 2005-07-28 | Egis Gyogyszergyar Nyilvanosan | Deramcyclane fumarate tablets and process for producing them |
| HUP0301906A3 (en) * | 2003-06-23 | 2006-03-28 | Egis Gyogyszergyar Nyilvanosan | Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity |
| EP1500391A1 (de) * | 2003-07-24 | 2005-01-26 | Neuro3D | Medizinische Verwendung von Bicycloheptan-Derivaten |
| CN1946386A (zh) * | 2004-03-12 | 2007-04-11 | 埃吉斯药物工厂 | 作为镇痛药的德伦环烷和阿片类的组合 |
| US20080021016A1 (en) * | 2004-03-12 | 2008-01-24 | Levay Gyoergy | Combined Pharmaceutical Composition for the Inhibition of the Decline of Cognitive Functions |
| KR101642113B1 (ko) | 2014-10-08 | 2016-07-25 | 원광대학교산학협력단 | 퇴행성 뇌질환을 예방, 개선 또는 치료하는 유황의 법제 방법 및 상기 방법으로 법제된 유황 |
| US11478467B2 (en) | 2017-05-04 | 2022-10-25 | Sreenivasarao Vepachedu | Targeted drug rescue with novel compositions, combinations, and methods thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU179164B (en) * | 1979-12-14 | 1982-08-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing cycloalkyl-ethers of alkanolamines |
| HU226061B1 (en) * | 1996-10-17 | 2008-04-28 | Egis Gyogyszergyar Nyilvanosan | 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation |
| HU227114B1 (en) * | 1999-05-11 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same |
| US6335371B1 (en) * | 2000-11-28 | 2002-01-01 | Orion Corporation | Method for inducing cognition enhancement |
-
2001
- 2001-07-18 HU HU0103017A patent/HUP0103017A3/hu unknown
-
2002
- 2002-07-18 EP EP02745700A patent/EP1408940B1/de not_active Expired - Lifetime
- 2002-07-18 KR KR10-2004-7000792A patent/KR20040017326A/ko active IP Right Grant
- 2002-07-18 UA UA2004021167A patent/UA78714C2/uk unknown
- 2002-07-18 PL PL02365258A patent/PL365258A1/xx not_active Application Discontinuation
- 2002-07-18 DE DE60228968T patent/DE60228968D1/de not_active Expired - Fee Related
- 2002-07-18 IL IL15984102A patent/IL159841A0/xx unknown
- 2002-07-18 JP JP2003513535A patent/JP2004537548A/ja active Pending
- 2002-07-18 SK SK31-2004A patent/SK312004A3/sk not_active Application Discontinuation
- 2002-07-18 CA CA002453834A patent/CA2453834A1/en not_active Abandoned
- 2002-07-18 CN CNA028163729A patent/CN1545410A/zh active Pending
- 2002-07-18 US US10/483,808 patent/US20040171696A1/en not_active Abandoned
- 2002-07-18 AT AT02745700T patent/ATE408403T1/de not_active IP Right Cessation
- 2002-07-18 CZ CZ200460A patent/CZ200460A3/cs unknown
- 2002-07-18 WO PCT/HU2002/000069 patent/WO2003007926A2/en active IP Right Grant
- 2002-07-18 EA EA200400192A patent/EA006897B1/ru not_active IP Right Cessation
- 2002-07-18 RS YU4904A patent/RS4904A/sr unknown
-
2004
- 2004-01-22 ZA ZA200400481A patent/ZA200400481B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ200460A3 (cs) | 2004-05-12 |
| EA006897B1 (ru) | 2006-04-28 |
| CN1545410A (zh) | 2004-11-10 |
| IL159841A0 (en) | 2004-06-20 |
| KR20040017326A (ko) | 2004-02-26 |
| PL365258A1 (en) | 2004-12-27 |
| HUP0103017D0 (en) | 2001-10-28 |
| WO2003007926A2 (en) | 2003-01-30 |
| DE60228968D1 (de) | 2008-10-30 |
| SK312004A3 (en) | 2004-06-08 |
| ZA200400481B (en) | 2005-01-24 |
| EP1408940A2 (de) | 2004-04-21 |
| WO2003007926A3 (en) | 2003-09-18 |
| RS4904A (en) | 2006-10-27 |
| JP2004537548A (ja) | 2004-12-16 |
| HUP0103017A3 (en) | 2004-05-28 |
| US20040171696A1 (en) | 2004-09-02 |
| CA2453834A1 (en) | 2003-01-30 |
| HUP0103017A2 (hu) | 2003-07-28 |
| EP1408940B1 (de) | 2008-09-17 |
| EA200400192A1 (ru) | 2004-06-24 |
| UA78714C2 (en) | 2007-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
| UY27368A1 (es) | Nuevos compuestos | |
| SE0104334D0 (sv) | Therapeutic agents | |
| BR0200782A (pt) | Compostos para o tratamento da isquemia | |
| CA2407100A1 (en) | 1-aroyl-piperidinyl benzamidines | |
| BR0111206A (pt) | Derivados de arilmetilamina para uso como inibidores de triptase | |
| JO2282B1 (en) | Oxazole derivatives | |
| MY138252A (en) | Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease | |
| SE0104340D0 (sv) | New compounds | |
| SE0403006D0 (sv) | New compounds | |
| MA29619B1 (fr) | Derive de 1,1 -dioxyde de 1,4-benzothiazepine, procede de preparation, medicaments comprenant ce compose, et utilisation de celui-ci comme hypolipidemiant | |
| MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
| GEP20094605B (en) | Pyrazole derivatives, compositions containing such compounds and methods of use thereof | |
| HUP0105437A2 (hu) | Új malonsavszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
| SE0201544D0 (sv) | Novel compounds and thier use | |
| UA83233C2 (ru) | Замещенный 2-аминотетралин для лечения депрессии | |
| MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
| BG108498A (en) | New derivatives of oxazolidinones as antibacterial agents | |
| YU87202A (sh) | Derivati arilmetilamina koji se koriste kao inhibitori triptaze | |
| AR028624A1 (es) | Heterociclilalquilaminas como antagonistas de receptores muscarinicos | |
| TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
| MXPA05010020A (es) | Derivados de oxamida. | |
| ATE333901T1 (de) | Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin | |
| ATE408403T1 (de) | Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon | |
| GB0212410D0 (en) | Organic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties | ||
| REN | Ceased due to non-payment of the annual fee |